Drug development
0 ATMP and biosimilars: challenges and how to overcome them

In this exclusive interview, Gopalan Narayanan from Voisin Consulting Life Sciences (UK), speaks about whether there are sufficient resources available to clinicians looking to adopt biosimilar’s, regulatory challenges during ATMP development and the potential of both of these products to transform the treatment of complex diseases.

Supportive oncology
0 The role of social media in cancer care

To mark our focus on social media in cancer care we recently spoke with Deanna Attai from the University of California (CA, USA) about the potential use of social media in cancer care including how oncologists can incorporate social media into their care plans as well as the opportunities and risks they should be aware of

1 2 3 6